MedTrace Logo

Neuromed- Integrated Health Life Platform and Biobank

NCT03279991 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2023-11-14

No results posted yet for this study

Summary

This project aims to create a digital platform for personal, clinical, diagnostic and environmental data collection, management and analysis of patients with cardiovascular and neurological disease or cancer admitted to the Neuromed Group clinics, associated with a biobanks of biological fluids and human tissues and a biotechnological platform for "omics" analysis, to encourage personalized, preventative and predictive care.

Conditions

Sponsors & Collaborators

  • Neuromed IRCCS

    lead OTHER

Principal Investigators

  • licia Iacoviello, MD, PhD · IRCCS Neuromed

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-04
Primary Completion
2023-02-27
Completion
2023-05-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03279991 on ClinicalTrials.gov